Results 161 to 170 of about 26,703 (203)

Environmental risk factors of neuromyelitis optica spectrum disorder: a systematic review. [PDF]

open access: yesTher Adv Neurol Disord
Mohammadi Lapevandani M   +4 more
europepmc   +1 more source

Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis. [PDF]

open access: yesJ Neurol
John N   +8 more
europepmc   +1 more source

Eculizumab for the acute attack of neuromyelitis optica spectrum disorder. [PDF]

open access: yesFront Immunol
Zhuang Q   +12 more
europepmc   +1 more source

Hyperperfusion Improvement: A Potential Therapeutic Marker in Neuromyelitis Optica Spectrum Disorder (NMOSD). [PDF]

open access: yesDiagnostics (Basel)
Kimura K   +9 more
europepmc   +1 more source

Neuromyelitis optica

Current Treatment Options in Neurology, 2005
Neuromyelitis optica (Devic's syndrome) is an uncommon, idiopathic, demyelinating syndrome of the central nervous system that preferentially affects the optic nerves and spinal cord. It frequently is misdiagnosed as severe multiple sclerosis, but usually is readily distinguished from multiple sclerosis in fully developed cases because of its severity ...
Dean M, Wingerchuk, Brian G, Weinshenker
  +10 more sources

Neuromyelitis Optica

Current Treatment Options in Neurology, 2010
Neuromyelitis optica (NMO) or Devic's disease typically involves the optic nerves and the spinal cord and is most often relapsing. The pathogenesis is one of an acute inflammatory process targeting astrocytes and resulting in demyelination, as well as axonal injury.
William M, Carroll, Kazuo, Fujihara
openaire   +4 more sources

Home - About - Disclaimer - Privacy